Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update for IBI363 in combination with chemotherapy for MHC-II-negative locally advanced gastric cancer; the study is …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is exploring factors that influence immunotherapy response in mismatch repair-deficient or MSI-H gastric and gastro…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating bemarituzumab in FGFR2b-positive advanced or metastatic stomach or gastroesophageal junction adenocarcinom…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Evaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer Screening [NA]
Clinical trial update on evaluating the NEOmom gastric video capsule for gastric cancer screening; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Iparomlimab and Tuvonralimab (QL1706) with chemotherapy in previously untreated advanced or me…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery [NA]
This update describes a telehealth program to help patients manage dietary quality of life after stomach cancer surgery; the study is curren…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer [Phase 3]
This clinical trial update describes a Phase 3 study evaluating adebrelimab with or without apatinib mesilate in combination with SOX neoadj…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating QL1706-SOX versus SOX alone as neoadjuvant therapy for resectable diffuse-type gastric cancer (gastric cancer,…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: How Epigenetic Changes in hMLH1 Connect Lab Research With Diagnosis in Gastric Cancer
This clinical trial entry describes ongoing research into epigenetic changes in the MLH1 gene and their potential to aid gastric cancer diag…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer [Phase 2]
Phase 2 clinical trial AK104 for MSI-H/dMMR gastric cancer and colorectal cancer has an active-not-recruiting status.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Reconstruction With a Lawrence-Hunt Jejunal Pouch After Total Gastrectomy [NA]
Clinical trial update on reconstruction with a Lawrence-Hunt jejunal pouch after total gastrectomy for gastric cancer; the study is currentl…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Recurrence After Gastric and Intestinal Polyp Resection
ClinicalTrials.gov entry describing a study on recurrence after gastric and intestinal polyp resection, with status NOT_YET_RECRUITING. Spon…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence [Phase 2]
Phase 2 clinical trial evaluating hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel for gastric or gastroesophageal ju…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure [Phase 2]
Phase 2 clinical trial evaluating SHR-1701 in combination with rivoceranib (± SHR-2554) for advanced gastric cancer and gastroesophageal jun…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer
A clinical trial sponsored by Fudan University is evaluating fecal DNA methylation markers and Helicobacter pylori SNPs as diagnostic tests …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer [Phase 2]
The clinical trial update reports the completion of a Phase 2 study evaluating [68Ga]Ga-FAPI PET/CT imaging in gastric cancer and gastroesop…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy [Phase 2]
This document updates a Phase 2 trial evaluating Adebrelimab with Famitinib and Irinotecan for advanced gastric cancer after first-line ther…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET-imaging of Two Vartumabs in Patients With Solid Tumors [EARLY_Phase 1]
This early-phase PET-imaging trial evaluates two vartumabs in patients with solid tumors and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis [Phase 3]
A Phase 3 randomized trial is evaluating intraperitoneal paclitaxel plus systemic therapy versus systemic therapy alone in gastric cancer wi…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 trial evaluating the combination of durvalumab with the FLOT chemotherapy regimen in resectable gastric and gastroesophageal junct…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
A clinical trial is evaluating PET imaging targeting CLDN18.2 for detecting malignant tumors, with recruitment ongoing in gastric cancer, pa…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy [NA]
This clinical trial explores oral glutamine supplementation in gastric cancer patients after gastrectomy and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer [Phase 2]
Phase II trial (RAINSPOT) evaluating zolbetuximab combined with paclitaxel and ramucirumab in CLDN18.2-positive gastric and gastroesophageal…